Program illustration, not product packaging. Program availability and fulfillment are being finalized.
Sildenafil + Tadalafil + Vardenafil + Apomorphine
Explore the proposed sildenafil + tadalafil + vardenafil + apomorphine option, single-dose vial format questions and clinician-led safety review. Enrollment is not open.
- Sexual-health questions
- Medication interactions
- Clinician assessment
Proposed prescription option. Compounded preparations are not FDA-approved or reviewed by FDA for safety, effectiveness or quality. Clinician review required.
Program inquiry
Program pricing and availability are being finalized.
Ask ArcDiscuss the program by text. This does not place a medication order.
What is sildenafil + tadalafil + vardenafil + apomorphine?
This four-ingredient proposal combines three PDE5 inhibitors with apomorphine. A greater ingredient count does not establish a stronger, faster or safer result.
The proposed program lists single-dose vial formats under the name Quadruple Powered. A vial identifies packaging, not an administration route; the route and complete formulation must be confirmed.
Safety, program details & sources
Important medicine interactions
PDE5 medicines can cause a dangerous fall in blood pressure with nitrates. A clinician must review heart health, other medicines and product-specific contraindications before treatment.
Do not combine erectile-dysfunction medicines or add this proposed option to an existing prescription yourself. Seek urgent care for an erection lasting more than four hours or sudden vision or hearing changes.
Formulation and personal eligibility
A dissolving oral preparation is different from a swallowed approved tablet. A multi-ingredient compounded product is not made FDA-approved by containing an ingredient found in an approved medicine.
Clinical review is required. A program name, age alone or interest in a particular combination does not establish personal eligibility. Arc cannot select a product, route or dose.
Availability, cost and your next step
This page describes a proposed program. Enrollment, confirmed prices, inclusions and fulfillment are not available through SnapBody yet. There is no medication order or payment at this step.
Bring questions to Arc by text. Arc can explain the published information; a licensed clinician makes treatment and prescribing decisions. Do not change your existing care based on this page.
Can I start sildenafil + tadalafil + vardenafil + apomorphine through SnapBody today?
Treatment enrollment is not open through SnapBody. You can use Arc for coaching and general research alongside your own prescriber.
How much does sildenafil + tadalafil + vardenafil + apomorphine cost?
A confirmed treatment price has not been published.
Does 'Quadruple Powered' mean it works better?
That is a proposed program name, not comparative clinical evidence. Ask the clinician about evidence and risks for the exact ingredients, formulation and intended use.
Does asking Arc begin clinical care?
No. Asking Arc starts a coaching conversation. It does not establish clinical eligibility, begin an evaluation, approve a prescription or place an order.
SnapBody · Standard Care, Inc. Reviewed .